JS212 Plus JS111 in EGFR-Mutant Advanced NSCLC: A Phase II Study

Abroad (travel likely)RecruitingPHASE2

Conditions

Locally Advanced, Metastatic, or Recurrent Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Tianqing Chu, Ph.D.) · ctqxkyy@163.com · 086 18017321311
Contact: Principal Investigator (Tianqing Chu, Ph.D.)
Shanghai Chest Hospital, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Shun Lu, Ph.D.) · shun_lu@hotmail.com · 086 13601813062
Contact: Principal Investigator (Shun Lu, Ph.D.)

View source on ClinicalTrials.gov